Skip to main content

Table 2 Correlation between LATS2 expression and clinicopathological features

From: Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma

Patient characteristics

n

LATS2

P

–

+

Gender

   

0.973

 Male

135

88

47

 

 Female

29

19

10

 

Age

   

0.881

  ≤ 58

85

55

30

 

  > 58

79

52

27

 

Tumor diameter

   

0.077

 <5 cm

106

64

42

 

  ≥ 5 cm

58

43

15

 

Tumor location

   

0.603

 Upper

15

9

6

 

 Middle

104

66

38

 

 Lower

45

32

13

 

T stage

   

0.182

 T1–2

69

41

28

 

 T3–4

95

66

29

 

Lymph node metastasis

   

0.003

 Negative

104

59

45

 

 Positive

60

48

12

 

Histological grade

   

0.028

 Well

31

17

14

 

 Middle

97

60

37

 

 Poor

36

30

6

 

pTNM stage

   

0.005

 I

28

14

14

 

 II

85

51

34

 

 III

51

42

9

Â